The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.
 
Katherine Case
No Relationships to Disclose
 
Dylan J. Martini
No Relationships to Disclose
 
Melad Dababneh
No Relationships to Disclose
 
Bassel Nazha
Consulting or Advisory Role - Exelixis
 
Jacqueline T Brown
No Relationships to Disclose
 
Shreyas S. Joshi
No Relationships to Disclose
 
Vikram M. Narayan
No Relationships to Disclose
 
Kenneth Ogan
No Relationships to Disclose
 
Viraj A. Master
Honoraria - Ethicon
 
Bradley Curtis Carthon
No Relationships to Disclose
 
Omer Kucuk
No Relationships to Disclose
 
Lara Harik
Research Funding - Astellas Pharma (Inst)
 
Mehmet Asim Bilen
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Exelixis; Genomic Health; Janssen; Nektar; Pfizer; Sanofi; Seagen
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genome & Company (Inst); Incyte (Inst); Nektar (Inst); Peloton Therapeutics (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst); Xencor (Inst)